Surgical oncology device developer Onkos Surgical and orthopedic augmented reality dev Insight Medical Systems said this week they inked a partnership deal looking to explore the use of Insight’s Arvis augmented reality visualization and information system in musculoskeletal oncology.
Both companies said they are engaged in a pilot project looking to assess the use of Arvis during tumor surgery.
“The convergence of 3D imaging, modeling and printing with advanced simulation technology will be transformative for oncology surgeons. Oncology surgeons are working on complex pathologies that require precise surgical intervention. Augmented reality may present an interesting approach to navigating these complex reconstructions,” Dr. Shervin Oskouei of Atlanta’s Emory University School of Medicine said in a prepared statement.
The Arvis system, from Parsippany, N.J.-based Insight Medical Systems, is designed to aid in surgical plans through tracking and visualization displayed through a headset. The system can display a patient’s anatomy into the surgeon’s field of view during the surgical procedure to reveal anatomical structures below the surface, the company said.
“Onkos Surgical is investing heavily in capabilities and technology to bring innovation to musculoskeletal oncology surgeons. Augmented reality technology has the potential of simplifying the complex and providing surgeons with input and feedback that may improve the precision of surgical planning and interoperative workflow. This technology fits well with our portfolio of precision oncology solutions,” Onkos Surgical CEO & co-founder Patrick Treacy said in a prepared release.
“We’re excited to partner with Onkos, who is a leader in the field of orthopedic oncology. There is a great opportunity to improve precision and visualization in these complex procedures, and Onkos is an ideal partner to jointly develop a system that complements their expertise in surgical planning and implant design,” Insight Medical Systems R&D VP Jonathan Nielsen said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.